Tag: Tarsons products

IPO · Stocks

DMR Hydro IPO : Subscribe or NOT?

Its real ALPHA2 Comments

The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that

DMR Hydro SME IPO Business — DMR is engaged in providing engineering consultancy and due diligence services to hydropower, dams, roads, and railway tunnels. The services offered by the company include the entire life cycle of projects covering design & engineering, due diligence & regulatory, bid management & construction engineering, and quality & inspection

Key areas of Operation -Company has been working into renewables, water resources, mining, and urban infrastructure domains. The company has a presence across 11 states in India. Internationally the company provides services to over 5 countries including Nepal, Nigeria, Dubai, Germany, and Senegal.

Also READ : NYKAA IPO : SUBSCRIBE OR NOT

Also Read : Latent View IPO : Subscribe or NOT

Offer purpose —  The issue consists of a fresh equity issue of 798000 shares and offer for sale of 198000 shares. Offer is to Fund working capital requirements and General corporate purposes

Risks —

SME company so liquidity risk is a major risk

The company is operating in a highly competitive and fragmented segment. There are many big players as well

Strength

Presence in both domestic and international markets

A wide offering of engineering consultancy and due diligence services

Experienced management and dedicated employee base

Catering to diversified sectors

Accredited with various quality certificates

Future

Company is working on areas for consultancy which are kind of good for future. Sustainability of margins could be thing to look for

Valuations

Valuations are reasonable looking at future. In short term, Price looks at par

Should we apply?

For medium to long term, prospects looks ok

People having risk apetite and long term vision can apply if they can held this stock patiently as liquidity can be low after listing

In case you have any questions/ queries, please feel free to reach me through Contact Form

Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.

Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.

Learning · Stocks

Laboratory equipment Market, leaders, margins : some key charts

Its real ALPHA
IPO · Stocks

Tarsons products IPO : Subscribe or NOT?

Its real ALPHA3 Comments

The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that

Tarsons Products IPO– Tarsons Products Limited is a leading Indian life sciences company with more than three decades of experience in the production and supply of labware products.

Business — The company manufactures a range of quality labware products that helps advance scientific discovery and improve healthcare systems. The company’s product portfolio is classified into three broad categories including consumables, reusables. These Products are used in various laboratories across research organizations, academic institutes, pharmaceutical companies, Contract Research Organizations (CRO), diagnostic companies, and hospitals.

Region of Operation -Company has 5 manufacturing facilities located in West Bengal spread across approximately 20,000 sq. mts of area. The company has a strong distribution network across India comprising of over 141 authorized distributors as of March 31, 2021 and supplies its products to more than 40 countries.

Also READ : NYKAA IPO : SUBSCRIBE OR NOT

Also Read : Latent View IPO : Subscribe or NOT

Offer purpose —  The IPO comprises a fresh issue of equity shares up to ₹150 crore and an offer for sale (OFS) of ₹850 crore by existing shareholders and promoters. Company is planning to use IPO for Repayment/prepayment of all or certain of company’s borrowings; Funding a part of the capital expenditure for new manufacturing facility at Panchla, West Bengal (proposed expansion) and General corporate purposes

Risks —

High Import dependency

Competition with MNC players

Environmental concern on Plastics

Regional concentration of plants

Strength

Leading supplier of life sciences products

Extensive product offering

Large addressable market of life sciences industry

Well-equipped and automated manufacturing facilities

Strong sales and distribution network

Experienced Promoter backed by a strong management team

Future

Company is vertically integrated and equipped with automated support systems that help the company in maintaining quality, increasing productivity, and reducing costs. Its key manufacturing facilities are ISO 9001:2015 and ISO 13485:2016/NS-EN ISO 13485:2016 certified. Company is poised for bright prospects ahead. It is expanding to meet the rising demand for its products.

Valuations

Valuations are reasonable looking at future. In short term, Price looks expensive

Should we apply?

For medium to long term, prospects looks bright with good set of customers and looking at no listed peers, may be advantage to subscribe

One must apply if they can held this stock patiently and not looking for immediate returns

In case you have any questions/ queries, please feel free to reach me through Contact Form

Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.

Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.